Immuneering (IMRX) Total Liabilities (2020 - 2026)

Immuneering's Total Liabilities history runs 7 years deep, the most recent figure standing at $8.3 million for Q1 2026.

• In Q1 2026, Total Liabilities fell 6.19% year-over-year to $8.3 million; the TTM figure through Mar 2026 stood at $8.3 million (down 6.19% YoY), while the FY2025 annual figure was $13.5 million, up 19.18% from the prior year.
• Total Liabilities was $8.3 million for Q1 2026 at Immuneering, down from $13.5 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $13.5 million in Q4 2025 to a low of $8.3 million in Q1 2026.
• Historically, Total Liabilities has averaged $10.6 million across 5 years, with a median of $10.8 million in 2024.
• Biggest YoY gain for Total Liabilities was 105.23% in 2022; the steepest drop was 70.59% in 2022.
• A 5-year view of Total Liabilities shows it stood at $12.5 million in 2022, then decreased by 4.06% to $12.0 million in 2023, then decreased by 5.66% to $11.3 million in 2024, then increased by 19.18% to $13.5 million in 2025, then tumbled by 38.59% to $8.3 million in 2026.
• The last three Total Liabilities figures came in at $8.3 million (Q1 2026), $13.5 million (Q4 2025), and $13.1 million (Q3 2025), per Business Quant data.